New Trump vaccine order based on "no credible scientific evidence," doctors say
Even Danish researchers think it's bizarre.
Signal weather
Stable
The story has moved beyond the first headline and now acts as a reliable context anchor.
The American Medical Association came out swinging this weekend at an executive order President Trump signed Friday that reaffirms intentions to model US childhood vaccine recommendations after those of Denmark—a country with universal healthcare, less diversity, and a population about the size of Maryland's. “There is no credible scientific evidence to support," such a change, AMA President Bobby Mukkamala said in a statement. The current vaccine schedule "is built on decades of rigorous research and real-world data, and it is designed to protect children in the US when they are most vulnerable based on our nation’s disease burden," he said. The plan to align federal childhood vaccine recommendations with Denmark's was first revealed by anti-vaccine Health Secretary Robert F. Kennedy Jr. in January. The overhaul would see the total number of recommended immunizations drop from 17 to 11, walking back recommendations for shots against rotavirus, COVID-19, influenza, meningococcal disease, hepatitis A, and hepatitis B. It stemmed from a December executive order by Trump to align US vaccine recommendations with the "best practices from peer, developed countries."Read full article Comments
Stay on the signal
Follow New Trump vaccine order based on "no credible scientific evidence," doctors say
Follow this story beyond a single article: new follow-ups, adjacent sources, and the evolving storyline.
Story map
Understand this topic fast
A quick entry into the story: why it matters now, who is involved, and where to go next for context.
Why it matters now
Topic constellation
Open the live map for this story
See which entities, story threads, sources, and follow-up articles shape this story right now.
Click nodes to continue
Entity pages
Story timeline
Continue with this story
A short sequence of events and follow-up stories to understand the arc quickly.
How reliable this looks
Signal and trust for Ars Technica
This source works at a rapid pace: 100% of recent stories land in the hot window, and 0% carry visible search signal.
Reliability
92
Freshness
100
Sources in storyline
1
Related articles
More stories that share tags, source, or category context.
Key mission for Europe's commercial space enterprise scrubbed again
Isar Aerospace is not hurting for money, but it is sorely lacking in the currency of flight experience.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
Heart protection from COVID shots remains amid updates, study finds
Despite continued benefits, anti-vaccine rhetoric has driven down vaccination.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
Chipmaker Nvidia seeks to raise over $25B in first bond deal since 2021
Debt sale set to test investor appetite for further exposure to AI sector amid a deluge of borrowing.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
A Chinese rocket breaks apart dangerously close to the Starlink constellation
The rocket's breakup likely generated 100 to 150 new pieces of space junk.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
More from Ars Technica
Fresh reporting and follow-up coverage from the same newsroom.
Key mission for Europe's commercial space enterprise scrubbed again
Isar Aerospace is not hurting for money, but it is sorely lacking in the currency of flight experience.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
Heart protection from COVID shots remains amid updates, study finds
Despite continued benefits, anti-vaccine rhetoric has driven down vaccination.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
UK to ban social media for kids under 16, may impose overnight curfews
Critics say bans push kids to riskier alternatives and can be beaten with VPNs.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.
Chipmaker Nvidia seeks to raise over $25B in first bond deal since 2021
Debt sale set to test investor appetite for further exposure to AI sector amid a deluge of borrowing.
Signal weather
Momentum is building quickly, so this card is a good early entry point into the topic.
Why now
Fresh coverage with immediate momentum.